Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease

27 Aug 2011

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipose Tissue and Metabolism
Share to Genetic Neurodegenerative Diseases
Share to Mitochondrial Function and Pathology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 21907283
DOI: 10.1016/j.nbd.2011.08.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PPARgamma rescue of the mitochondrial dysfunction in Huntington's diseasePMID 21907283Read ↗

PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeuticallySemantic proximity Read ↗

PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disordersSemantic proximity Read ↗

PGC-1α, mitochondrial dysfunction, and Huntington's diseaseSemantic proximity Read ↗

New therapeutic target for metabolic syndrome: PPARdelta.Semantic proximity Read ↗

Mechanistic insights on the role of Nrf-2 signalling in Huntington’s diseaseSemantic proximity Read ↗

Dysregulation of PGC-1α-Dependent Transcriptional Programs in Neurological and Developmental Disorders: Therapeutic Challenges and OpportunitiesSemantic proximity Read ↗

Impaired mitochondrial trafficking in Huntington's diseaseSemantic proximity Read ↗

Neuroprotective effects of <scp>PPAR</scp>‐γ agonist rosiglitazone in N171‐82Q mouse model of Huntington's diseaseSemantic proximity Read ↗

PGC-1α, a New Therapeutic Target in Huntington's Disease?Semantic proximity Read ↗

PGC-1α at the intersection of bioenergetics regulation and neuron function: From Huntington's disease to Parkinson's disease and beyondSemantic proximity Read ↗

Glitazones, PPAR-γ and NeuroprotectionSemantic proximity Read ↗

Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic targetSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.